Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
Zafar Ali, Founder of Guardians of Humanity Pakistan, shared a post on LinkedIn:
“How Does Hemoglobin Know When to Hold Oxygen – and When to Let It Go?
The Hemoglobin–Oxygen Dissociation Curve is one of the most important concepts for understanding oxygen transport in the human body.
It explains how hemoglobin’s affinity for oxygen changes as oxygen partial pressure (PO₂) changes.
1. Oxygen Loading in the Lungs
In the lungs, PO₂ is high. Hemoglobin binds oxygen efficiently, allowing red blood cells to become highly oxygenated before carrying O₂ to the tissues.
2. Cooperative Binding
Hemoglobin has four heme groups. When one O₂ molecule binds, hemoglobin’s affinity for additional O₂ molecules increases. This cooperative binding produces the characteristic sigmoid (S-shaped) curve.
3. Oxygen Unloading in Tissues
As blood reaches tissues, PO₂ decreases. Hemoglobin releases oxygen, making it available for cellular respiration. Active tissues can promote even greater oxygen unloading.
4. What Causes a Right Shift?
A rightward shift means decreased hemoglobin affinity for oxygen. This promotes greater oxygen release to metabolically active tissues.
Key factors include:
- Increased temperature
- Increased CO₂
- Decreased pH or increased H⁺
- Increased 2,3-BPG
This relationship is often summarized by the Bohr effect: increased CO₂ and acidity in metabolically active tissues favor oxygen unloading.
The Big Picture
- Lungs have high PO₂, leading to oxygen loading.
- Tissues have lower PO₂, leading to oxygen unloading.
- Active tissues have more CO₂, H⁺, and heat, leading to enhanced O₂ delivery.
The curve is a beautiful example of how physiology matches oxygen delivery to tissue demand.
Save this for your next physiology, medicine, nursing, or biology study session.
Which physiology concept should I explain next?”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:02Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal